Doliver Advisors LP Lowers Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Doliver Advisors LP decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 43.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,751 shares of the healthcare conglomerate’s stock after selling 1,337 shares during the period. Doliver Advisors LP’s holdings in UnitedHealth Group were worth $886,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Hanlon Investment Management Inc. purchased a new stake in shares of UnitedHealth Group during the second quarter valued at $200,000. Parcion Private Wealth LLC raised its holdings in shares of UnitedHealth Group by 22.6% during the second quarter. Parcion Private Wealth LLC now owns 1,500 shares of the healthcare conglomerate’s stock valued at $764,000 after purchasing an additional 277 shares during the last quarter. Norden Group LLC boosted its holdings in UnitedHealth Group by 15.6% in the second quarter. Norden Group LLC now owns 6,080 shares of the healthcare conglomerate’s stock worth $3,097,000 after purchasing an additional 820 shares during the last quarter. Umpqua Bank raised its stake in UnitedHealth Group by 3.5% during the 2nd quarter. Umpqua Bank now owns 5,412 shares of the healthcare conglomerate’s stock valued at $2,756,000 after buying an additional 184 shares during the last quarter. Finally, Strategic Financial Concepts LLC boosted its stake in shares of UnitedHealth Group by 43,843.0% in the 2nd quarter. Strategic Financial Concepts LLC now owns 232,019 shares of the healthcare conglomerate’s stock worth $118,158,000 after buying an additional 231,491 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on UNH. Morgan Stanley dropped their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. KeyCorp assumed coverage on UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. UBS Group cut their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Finally, Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $627.58.

UnitedHealth Group Price Performance

Shares of UNH stock traded up $0.26 on Monday, reaching $513.26. The company’s stock had a trading volume of 2,388,004 shares, compared to its average volume of 3,186,897. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a market capitalization of $472.34 billion, a price-to-earnings ratio of 33.44, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The stock’s fifty day simple moving average is $559.83 and its 200-day simple moving average is $561.31. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm posted $6.56 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.64%. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.